This inventor holds 1 USPTO granted patent. Top assignee: Credia Japan Co., Ltd.. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: **The Innovative Contributions of Madoka Tonosaki**
Introduction
Madoka Tonosaki is a distinguished inventor based in Saitama, Japan. His innovative spirit has led him to develop a unique method for synthesizing functional peptide nucleic acids (PNA). This groundbreaking work has significant implications for the field of molecular biology and biotechnology.
Latest Patents
Tonosaki holds a patent for his invention titled "Functional peptide nucleic acid and its production method." This patent introduces a novel method for synthesizing functional PNA with superior cost performance, enabling the rapid introduction of functional molecules. The process involves reacting a PNA monomer unit, protected by a protecting group, with Fmoc-ω-amino acid-PNA-OH. Following the synthesis of the PNA oligomer, a functional molecule with a free carboxylic acid is incorporated, completing the innovative production method.
Career Highlights
Currently, Madoka Tonosaki is employed at Credia Japan Co., Ltd., where he continues to advance his research and contributions to the field. His unique insights and expertise in functional peptide nucleic acids position him as a valuable asset to his company and the broader scientific community.
Collaborations
Throughout his career, Tonosaki has worked closely with Hisafumi Ikeda, a fellow innovator. Their collaboration has focused on pushing the boundaries of molecular synthesis, fostering a creative environment that nurtures advancements in their respective fields.
Conclusion
Madoka Tonosaki’s innovative contributions in the realm of functional peptide nucleic acids are paving the way for exciting developments in biotechnology. With his patent and collaborative efforts, he exemplifies the impact one inventor can have in shaping the future of science and technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile